Cefiderocol
Infections caused by multidrug-resistant Gram-negative bacteria
ApprovedCommercial (partnered with Shionogi)
Key Facts
Indication
Infections caused by multidrug-resistant Gram-negative bacteria
Phase
Approved
Status
Commercial (partnered with Shionogi)
Company
About Meiji Seika Pharma
Japanese pharmaceutical company developing innovative anti-infectives and oncology drugs through small molecule discovery platforms.
View full company profile